Abbott Laboratories (ABT)vsCONMED Corporation (CNMD)
ABT
Abbott Laboratories
$105.62
-2.20%
HEALTHCARE · Cap: $177.07B
CNMD
CONMED Corporation
$46.99
+8.74%
HEALTHCARE · Cap: $1.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 3299% more annual revenue ($46.59B vs $1.37B). ABT leads profitability with a 11.7% profit margin vs 4.0%. CNMD appears more attractively valued with a PEG of 1.84. CNMD earns a higher WallStSmart Score of 59/100 (C).
ABT
Buy52
out of 100
Grade: C-
CNMD
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-46.2%
Fair Value
$73.35
Current Price
$105.62
$32.27 premium
Margin of Safety
+27.2%
Fair Value
$58.17
Current Price
$46.98
$11.19 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 136.8% YoY
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Earnings declined 47.5%
Expensive relative to growth rate
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of 5.4% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. Revenue growth of 13.0% demonstrates continued momentum.
Bull Case : CNMD
The strongest argument for CNMD centers on Price/Book, EPS Growth.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.
Bear Case : CNMD
The primary concerns for CNMD are PEG Ratio, Altman Z-Score, Market Cap. Thin 4.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
CNMD carries more volatility with a beta of 0.93 — expect wider price swings.
ABT is growing revenue faster at 13.0% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CNMD scores higher overall (59/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →CONMED Corporation
HEALTHCARE · MEDICAL DEVICES · USA
CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?